You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 9,403,772


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,403,772 protect, and when does it expire?

Patent 9,403,772 protects AKYNZEO and is included in one NDA.

This patent has sixty-six patent family members in forty-nine countries.

Summary for Patent: 9,403,772
Title:4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tol- yl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-ium as a neurokinin receptor modulator
Abstract: Compounds and methods for the prevention and/or treatment of diseases which are pathophysiologically mediated by the neurokinin (NK.sub.1) receptor, based on 4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-to- lyl)3yridine-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-ium and pharmaceutically acceptable salts thereof.
Inventor(s): Fadini; Luca (Giubiasco, CH), Manini; Peter (Giubiasco, CH), Pietra; Claudio (Como, IT), Giuliano; Claudio (Como, IT), Lovati; Emanuela (Mendrisio, CH), Cannella; Roberta (Varese, IT), Venturini; Alessio (Varese, IT), Stella; Valentino J (Lawrence, KS)
Assignee: HELSINN HEALTHCARE SA (Lugano/Pazzallo, CH)
Application Number:14/360,991
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,403,772
Patent Claim Types:
see list of patent claims
Use; Compound;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patent 9,403,772: A Detailed Analysis

Introduction to U.S. Patents and the USPTO

The United States Patent and Trademark Office (USPTO) is the agency responsible for granting U.S. patents and registering trademarks. Patents are primary indicators of invention, providing exclusive rights to inventors for their creations[1].

Overview of U.S. Patent 9,403,772

To analyze the scope and claims of U.S. Patent 9,403,772, it is essential to understand the patent's title, abstract, and the specific claims made.

Title and Abstract

While the specific details of U.S. Patent 9,403,772 are not provided in the sources, a typical analysis would start with the title and abstract. These sections give a broad overview of the invention, including its purpose, functionality, and key features.

Claims

The claims section of a patent is crucial as it defines the scope of the invention. Claims are the legal boundaries that distinguish the invention from prior art and other existing technologies. Here are some key points to consider:

  • Independent Claims: These are the broadest claims that define the invention without referencing other claims.
  • Dependent Claims: These claims build upon the independent claims, often narrowing down the scope by adding additional features or limitations.
  • Claim Structure: Claims are typically written in a specific format, starting with a preamble that introduces the invention, followed by a body that details the elements and their relationships[3].

Analyzing the Scope of the Patent

Technological Classification

Patents are classified into various technological fields based on the World Intellectual Property Organization (WIPO) classification system. This helps in understanding the broader technological area in which the patent resides. For example, patents can be classified into fields such as electrical engineering, mechanical engineering, or chemistry[1].

Comparison with Prior Art

The scope of a patent is also determined by how it differs from prior art. Prior art includes all existing knowledge and inventions in the same field. The patent must be novel, nonobvious, and sufficiently useful to be granted[1].

Claims Analysis

Claim Types

  • Method Claims: These describe a process or method of achieving a particular result.
  • Apparatus Claims: These describe a physical device or system.
  • System Claims: These describe a combination of components that work together to achieve a specific function.
  • Composition of Matter Claims: These describe a new chemical compound or material.

Claim Limitations

Each claim includes specific limitations that define the invention. These limitations can include structural elements, functional relationships, and operational steps. The more detailed and specific the claims, the narrower the scope of the patent, but the stronger the protection against infringement.

Patent Landscape

Industry Trends

The patent landscape is influenced by industry trends and technological advancements. For instance, the computer and electronics manufacturing industry has seen a significant increase in patenting activity, reflecting the rapid innovation in these fields[1].

Competitor Analysis

Understanding the patent landscape involves analyzing competitors' patents in the same technological field. This includes identifying key players, their patent portfolios, and the specific technologies they are protecting.

Geographic Distribution

Patents can be allocated geographically based on the inventor's location. This helps in understanding the global distribution of innovation and where specific technologies are being developed[1].

Legal and Regulatory Aspects

Patent Trial and Appeal Board (PTAB)

The PTAB plays a crucial role in determining the validity of patent claims through inter partes review (IPR) and other proceedings. Decisions from the PTAB can significantly impact the scope and claims of a patent, as seen in cases like IOENGINE, LLC v. INGENICO INC, where certain claims were found unpatentable[2].

Patent Scope Measurements

The USPTO provides datasets and research papers that help in measuring patent scope. These measurements include claim-level statistics and document-level statistics, which can be used to analyze the breadth and depth of patent claims[3].

Practical Implications for Business

Innovation and R&D

Companies involved in research and development (R&D) need to closely monitor patent trends and the patent landscape to ensure their innovations are protected and do not infringe on existing patents. High R&D industries, such as computer and electronics manufacturing, have high rates of patenting, which is crucial for their competitive edge[1].

Licensing and Collaboration

Understanding the scope and claims of patents can facilitate licensing agreements and collaborations. Companies can identify potential partners or licensing opportunities by analyzing the patent portfolios of other firms.

Key Takeaways

  • Patent Claims: The claims section of a patent defines its legal boundaries and distinguishes it from prior art.
  • Technological Classification: Patents are classified into specific technological fields, which helps in understanding industry trends and competitor activity.
  • Legal and Regulatory: The PTAB and other legal mechanisms play a critical role in determining the validity of patent claims.
  • Practical Implications: Understanding patent scope and claims is essential for R&D, licensing, and collaboration strategies.

FAQs

Q: What is the primary purpose of the claims section in a patent? A: The claims section defines the legal boundaries of the invention, distinguishing it from prior art and other existing technologies.

Q: How are patents classified technologically? A: Patents are classified using the World Intellectual Property Organization (WIPO) classification system, which includes 35 technical fields.

Q: What is the role of the Patent Trial and Appeal Board (PTAB) in patent disputes? A: The PTAB determines the validity of patent claims through inter partes review (IPR) and other proceedings.

Q: Why is it important for companies to monitor patent trends and the patent landscape? A: Monitoring patent trends helps companies ensure their innovations are protected, avoid infringement, and identify potential licensing or collaboration opportunities.

Q: How do high R&D industries benefit from patenting? A: High R&D industries benefit from patenting by protecting their innovations, which is crucial for their competitive edge and continued innovation.

Sources

  1. National Science Foundation. Invention: U.S. and Comparative Global Trends. January 15, 2020.
  2. United States Court of Appeals for the Federal Circuit. IOENGINE, LLC v. INGENICO INC. May 3, 2024.
  3. United States Patent and Trademark Office. Patent Claims Research Dataset. August 28, 2017.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,403,772

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Helsinn Hlthcare AKYNZEO fosnetupitant chloride hydrochloride; palonosetron hydrochloride POWDER;INTRAVENOUS 210493-001 Apr 19, 2018 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y USE IN COMBINATION WITH DEXAMETHASONE IN ADULTS FOR THE PREVENTION OF ACUTE AND DELAYED NAUSEA AND VOMITING ASSOCIATED WITH INITIAL AND REPEAT COURSES OF HIGHLY EMETOGENIC CANCER CHEMOTHERAPY ⤷  Subscribe
Helsinn Hlthcare AKYNZEO fosnetupitant chloride hydrochloride; palonosetron hydrochloride SOLUTION;INTRAVENOUS 210493-002 May 27, 2020 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y USE IN COMBINATION WITH DEXAMETHASONE IN ADULTS FOR THE PREVENTION OF ACUTE AND DELAYED NAUSEA AND VOMITING ASSOCIATED WITH INITIAL AND REPEAT COURSES OF HIGHLY EMETOGENIC CANCER CHEMOTHERAPY ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,403,772

PCT Information
PCT FiledNovember 28, 2012PCT Application Number:PCT/US2012/066778
PCT Publication Date:June 06, 2013PCT Publication Number: WO2013/082102

International Family Members for US Patent 9,403,772

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 2785706 ⤷  Subscribe 301047 Netherlands ⤷  Subscribe
European Patent Office 2785706 ⤷  Subscribe CA 2020 00028 Denmark ⤷  Subscribe
European Patent Office 2785706 ⤷  Subscribe PA2020510 Lithuania ⤷  Subscribe
European Patent Office 2785706 ⤷  Subscribe LUC00158 Luxembourg ⤷  Subscribe
European Patent Office 2785706 ⤷  Subscribe 2020C/516 Belgium ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.